Minocycline – what’s it all about?
It was criticized that I selected the study data on Ocrelizumab as my personal highlight of the last ECTRIMS meeting and did not dedicate a single line to the data on Minocycline. I would like
Continue reading
Year: 2015
Pegylated Interferon-beta – an interesting alternative for the basic therapy of MS
Nowadays, multiple sclerosis is primarily treated with oral medications such as dimethyl fumarate or teriflunomide in many cases. The interferon preparations, which were the standard in basic therapy for many years, have a bad reputation
Continue reading
News from ECTRIMS
The annual ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) conference took place during the second week of October. Over 9,000 clinical and scientific MS experts from all regions of the world gathered
Continue reading
Sleep Disorders in MS
The sleep of MS patients is rather less discussed in practice – although sleep disorders are a problem not to be underestimated and are probably more common than is generally assumed. Therefore, I would like
Continue reading
Pharmacological Therapy of Spasticity
Spasticity is a symptom many MS patients suffer from. But what is spasticity exactly? It is not so easy to explain in a few words: Spasticity results from the disinhibition of reflex arcs due to
Continue reading
MS and Pregnancy – Recommendations for Mild/Moderate MS
MS often affects young women, so the topic of pregnancy is interesting in many ways. One might think that many basic things are clear and one is primarily confronted with very specific questions. Surprisingly, however,
Continue reading
Side Effects of Tecfidera – A Brief Excursion
Tecfidera (Dimethyl Fumarate) has been approved since January 2014 for the treatment of relapsing-remitting multiple sclerosis. Many patients have been waiting for this medication due to positive study results, while others are excited about the
Continue reading
The Crux of the “Joint Decision”
The self-determining patient is all the rage – politicians emphasize this claim again and again. It is an essential part of the new Patient Rights Act and doctors are often criticized for their approach being
Continue reading
The Question of the Right Dosage
The question of the correct dosage of immunomodulatory drugs has often been discussed in the comments. Many patients do not understand why doctors usually use the full (approved) dose of a drug, even though a
Continue readingTattoos and MS – Objections?!
One of my patients recently asked me whether I would have any objections to him getting another tattoo. The plan seems to be for a somewhat larger piece and he had previously had some intense
Continue reading
